These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 37114781)
1. Computational Insight into the Mechanism of Action of DNA Gyrase Inhibitors; Revealing a New Mechanism. Muhammed MT; Aki-Yalcin E Curr Comput Aided Drug Des; 2024; 20(3):224-235. PubMed ID: 37114781 [TBL] [Abstract][Full Text] [Related]
2. Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors. Azam MA; Thathan J SAR QSAR Environ Res; 2017 Apr; 28(4):275-296. PubMed ID: 28399673 [TBL] [Abstract][Full Text] [Related]
3. Structure based design and synthesis of 3-(7-nitro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanehydrazide derivatives as novel bacterial DNA-gyrase inhibitors: In-vitro, In-vivo, In-silico and SAR studies. Saleh MA; Elmaaty AA; El Saeed HS; Saleh MM; Salah M; Ezz Eldin RR Bioorg Chem; 2022 Dec; 129():106186. PubMed ID: 36215786 [TBL] [Abstract][Full Text] [Related]
4. Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking. Alagumuthu M; Muralidharan VP; Andrew M; Ahmed MH; Iyer SK; Arumugam S Mol Inform; 2018 Dec; 37(12):e1800048. PubMed ID: 30051592 [TBL] [Abstract][Full Text] [Related]
5. Identification of promising anti-DNA gyrase antibacterial compounds using Islam MA; Pillay TS J Biomol Struct Dyn; 2020 Apr; 38(6):1798-1809. PubMed ID: 31084271 [TBL] [Abstract][Full Text] [Related]
7. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study. Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559 [TBL] [Abstract][Full Text] [Related]
8. Pharmacophore-Based Virtual Screening and Molecular Dynamics Simulation for Identification of a Novel DNA Gyrase B Inhibitor with Benzoxazine Acetamide Scaffold. Elseginy SA; Anwar MM ACS Omega; 2022 Jan; 7(1):1150-1164. PubMed ID: 35036778 [TBL] [Abstract][Full Text] [Related]
9. Prediction Mechanism of Nevadensin as Antibacterial Agent against Shadrina AAN; Herdiyati Y; Wiani I; Satari MH; Kurnia D Comb Chem High Throughput Screen; 2022; 25(9):1488-1497. PubMed ID: 34238151 [TBL] [Abstract][Full Text] [Related]
10. Antibacterial potential of Thymus linearis essential oil collected from Wasturwan mountain: A combination of experimental and theoretical studies involving in silico molecular docking simulation of the major compounds against Novobiocin-resistant mutant of DNA Gyrase-B. Firdous S; Bhat SH; Aziz S; Jehangir M; Syeed S; Iqra Z; Ahmad MA; Rasool S; Khursheed A; Shalla AH; Ganaie AA; Rather MA Microb Pathog; 2023 Oct; 183():106280. PubMed ID: 37541555 [TBL] [Abstract][Full Text] [Related]
11. In silico study directed towards identification of the key structural features of GyrB inhibitors targeting MTB DNA gyrase: HQSAR, CoMSIA and molecular dynamics simulations. Kamsri P; Punkvang A; Hannongbua S; Suttisintong K; Kittakoop P; Spencer J; Mulholland AJ; Pungpo P SAR QSAR Environ Res; 2019 Nov; 30(11):775-800. PubMed ID: 31607177 [No Abstract] [Full Text] [Related]
12. Exploring the 5-Substituted 2-Aminobenzothiazole-Based DNA Gyrase B Inhibitors Active against ESKAPE Pathogens. Sterle M; Durcik M; Stevenson CEM; Henderson SR; Szili PE; Czikkely M; Lawson DM; Maxwell A; Cahard D; Kikelj D; Zidar N; Pal C; Mašič LP; Ilaš J; Tomašič T; Cotman AE; Zega A ACS Omega; 2023 Jul; 8(27):24387-24395. PubMed ID: 37457471 [TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulation of bioactive compounds of Begum S; Shadrack DM; Joseph FM; Ndensendo VMK J Biomol Struct Dyn; 2022; 40(19):9279-9286. PubMed ID: 34018468 [TBL] [Abstract][Full Text] [Related]
14. Identification of potential inhibitors against E.coli via novel approaches based on deep learning and quantum mechanics-based atomistic investigations. Aziz M; Ejaz SA; Alsfouk BA; Sultan A; Li C Arch Biochem Biophys; 2023 Oct; 747():109761. PubMed ID: 37734644 [TBL] [Abstract][Full Text] [Related]
15. Structure based drug discovery and in vitro activity testing for DNA gyrase inhibitors of Salmonella enterica serovar Typhi. Sharma P; Kumar M; Dahiya S; Sood S; Das BK; Kaur P; Kapil A Bioorg Chem; 2020 Nov; 104():104244. PubMed ID: 32966903 [TBL] [Abstract][Full Text] [Related]
16. De novo design of novel DNA-gyrase inhibitors based on 2D molecular fingerprints. Huang Z; Lin K; You Q Bioorg Med Chem Lett; 2013 Jul; 23(14):4166-71. PubMed ID: 23743285 [TBL] [Abstract][Full Text] [Related]
17. Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase. Liu H; Chu ZW; Xia DG; Cao HQ; Lv XH Bioorg Chem; 2020 Jun; 99():103807. PubMed ID: 32272364 [TBL] [Abstract][Full Text] [Related]
18. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents. Alagumuthu M; Arumugam S Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220 [TBL] [Abstract][Full Text] [Related]
19. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity. Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469 [TBL] [Abstract][Full Text] [Related]
20. Novel coumarin-thiazolyl ester derivatives as potential DNA gyrase Inhibitors: Design, synthesis, and antibacterial activity. Liu H; Xia DG; Chu ZW; Hu R; Cheng X; Lv XH Bioorg Chem; 2020 Jul; 100():103907. PubMed ID: 32413631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]